Regenerative Medical Solutions Inc. (RMS) services

RMS produces human induced pluripotent stem cell derived Islet-Like Clusters (ILC) for dual research tool and therapeutic use targeting diabetes. ILC were developed after over 15 years of research at the University of Wisconsin-Madison in the lab of world renowned researcher, Dr. Jon Odorico, MD, FACS and have undergone eight additional years of further research at RMS. This has resulted in several granted and pending patents to form a strong IP portfolio.